Advances in Molecular Imaging and Radionuclide Therapy of Neuroendocrine Tumors.

ABSTRACT: Neuroendocrine neoplasms make up a heterogeneous group of tumors with inter-patient and intra-patient variabilities. Molecular imaging can help to identify and characterize neuroendocrine tumors (NETs). Furthermore, imaging and treatment with novel theranostics agents offers a new, tailored approach to managing NETs. Recent advances in the management of NETs aim to enhance the effectiveness of targeted treatment with either modifications of known substances or the development of new substances with better targeting features. There have been several attempts to increase the detectability of NET lesions via positron emission tomography (PET) imaging and improvements in pretreatment planning using dosimetry. Especially notable is PET imaging with the radionuclide Copper-64. Increasing interes

SUBMITTER: Yordanova A 

PROVIDER: S-EPMC7697910 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature